Jennifer Dember, NP
Primary Care · Holmdel, NJNPI 1235890716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Medtronic$556
- Lilly USA, LLC$535
- AstraZeneca$404
- GSK$222
- AbbVie$195
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,634100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 69 | $1,091 |
| Medtronic | 29 | $556 |
| Lilly USA, LLC | 36 | $535 |
| AstraZeneca | 22 | $404 |
| GSK | 14 | $222 |
| AbbVie | 11 | $195 |
| Exact Sciences | 8 | $195 |
| Bayer | 9 | $163 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $162 |
| Lundbeck LLC | 8 | $149 |
| Boehringer Ingelheim | 9 | $145 |
| Dexcom, Inc. | 6 | $112 |
| Pfizer | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Sanofi-aventis U.S. LLC | 4 | $82 |
| Amgen | 4 | $65 |
| W. L. Gore & Associates, Inc. | 1 | $58 |
| Corcept Therapeutics | 3 | $52 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Merck | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Currax Pharmaceuticals LLC | 3 | $40 |
| Shockwave Medical, Inc | 1 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$4,634 in reported general payments places this provider in the 90th percentile of 330 primary care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 29 | $27,451 |
| Rosuvastatin Calcium | 40 | $909 |
| Atorvastatin Calcium | 56 | $619 |
| Levothyroxine Sodium | 55 | $607 |
| Fluticasone Propionate | 51 | $576 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $474 |
| Metoprolol Succinate | 25 | $363 |
| Methylprednisolone | 62 | $325 |
| Amlodipine Besylate | 58 | $310 |
| Olmesartan Medoxomil | 14 | $304 |
| CefuroximeCefuroxime Axetil | 31 | $278 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $265 |
| Duloxetine Hcl | 21 | $263 |
| Azithromycin | 64 | $229 |
| Escitalopram Oxalate | 21 | $225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $535 | $27,45129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 330 primary care providers in New Jersey.
Other primary care in Holmdel
- Althea Hill PayneHolmdel$4K
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.